Melanoma differentiation associated gene-9/syndecan binding protein promotes hepatocellular carcinoma,Hepatology

当前位置： X-MOL 学术 › Hepatology › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Melanoma differentiation associated gene-9/syndecan binding protein promotes hepatocellular carcinoma
Hepatology ( IF 13.5 ) Pub Date : 2022-09-19 , DOI: 10.1002/hep.32797
Debashri Manna ₁ , Saranya Chidambaranathan Reghupaty ₂ , Maria Del Carmen Camarena ₂ , Rachel G Mendoza ₁ , Mark A Subler ₁ , Jennifer E Koblinski _{3,

4} , Rebecca Martin _{3,

5} , Mikhail G Dozmorov ₆ , Nitai D Mukhopadhyay ₆ , Jinze Liu ₆ , Xufeng Qu ₃ , Swadesh K Das _{1,

3,

7} , Zhao Lai ₈ , Jolene J Windle _{1,

3,

7} , Paul B Fisher _{1,

3,

7} , Devanand Sarkar _{1,

3,

7}

Affiliation

The oncogene Melanoma differentiation associated gene-9/syndecan binding protein (MDA-9/SDCBP) is overexpressed in many cancers, promoting aggressive, metastatic disease. However, the role of MDA-9 in regulating hepatocellular carcinoma (HCC) has not been well studied.

中文翻译：